Abstract
Genetic Epilepsy (previously known as idiopathic epilepsy) is a result of a known or presumed genetic defect(s) that is not causative of a brain structural or metabolic disorder. Objectives: Genetic epilepsy with febrile seizures plus is characterized by multiple febrile seizures and by several subsequent types of afebrile generalized seizures with variable degrees of severity. It has a complex and heterogeneous clinical presentation. Dravet Syndrome (DS) is a catastrophic early-life epilepsy disorder of the GEFS plus spectrum in which the seizures are usually refractory to treatment and are associated with intellectual disability. The detection rate of gene variants has gradually increased, and in addition to providing an accurate diagnosis, elucidating the genetic cause of paediatric-onset drug-resistant epilepsy can also help guide clinical management. Method: Here, we selected cases with febrile seizures on presentation who later developed epilepsy, and evaluated those using genetic studies.Results: The genes SCN1A, ADGRV2, GABBR2, and GPR98 as potential causes of GEFS (+) and Dravet syndrome have been highlighted in our report. Conclusion: An improved understanding of the true physiopathology of genetic epilepsy and the identification of factors that are involved in phenotypic variations, will make it easier to understand genotype-phenotype correlations in the future and help implement individualized precision medical treatment regimens.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Paediatrics and Geriatrics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.